Focused on transformative treatment technologies in dermatology and oncology.
The Company's current focus is a range of dermatological applications utilising its unique formulation and delivery technologies to meet currently unmet needs in the skincare market.
Commercial Update
Watch The Sunday Roast featuring Tim McCarthy, Chairman of Incanthera PLC
Sunday Roast: Incanthera Winner of Q1 2024 Stock Performer, podcast interviews Tim McCarthy, Chairman of Incanthera PLC on Commercial Update and financial outlook